Academic article

• Kristine Eldevik Fasmer; Sunniva Lindås; Ankush Gulati et al. (2026). Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods. (external link)
• Tobias M.P. Hartwich; Seungji Choi; Ayoung Hwang et al. (2026). Integrated mutational landscape analysis of endometrial stromal sarcoma. (external link)
• Marike S. Lombaers; Casper Reijnen; Ally Sprik et al. (2025). ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment. (external link)
• Marit Louise Ulvang; Oda Vik Fløtre; Hege Fredriksen Berg et al. (2025). Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions. (external link)
• Kristine Eldevik Fasmer; Ankush Gulati; Sunniva Lindås et al. (2025). Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [18F]FDG PET primary tumor radiomics. (external link)
• Kristine Eldevik Fasmer; Jostein Sæterstøl; Maria Beate Svanes Ljunggren et al. (2025). Abdominal fat distribution in endometrial cancer: from diagnosis to follow-up. (external link)
• Gonda F.J. Konings; Niina Saarinen; Bert Delvoux et al. (2018). Development of an image-guided orthotopic xenograft mouse model of endometrial cancer with controllable estrogen exposure. (external link)
• Madalene Earp; Jonathan P. Tyrer; Stacey J. Winham et al. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. (external link)
• Shalaka S. Hampras; Lara E. Sucheston-Campbell; Rikki Cannioto et al. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. (external link)
• Mari Kyllesø Halle; Erlend Hodneland; Kari Strøno Wagner-Larsen et al. (2024). Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer. (external link)
• Hilde Renate Engerud; Hege Fredriksen Berg; Madeleine Myrvold et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (external link)
• Camilla Krakstad; Jone Trovik; Elisabeth Wik et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (external link)
• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2004). cAMP protects neutrophils against TNF?-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). (external link)
• Linda E. Kelemen; Kate Lawrenson; Jonathan Tyrer et al. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. (external link)
• Marta Brunetti; Valeria Vitelli; Anca Michaela Naas et al. (2025). Molecular Landscape of Endometrial Stromal Tumors. (external link)
• Mari Kyllesø Halle; Akinyemi I Ojesina; Hilde Renate Engerud et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (external link)
• Camilla Krakstad; Even Birkeland; Danila Seidel et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (external link)
• Fiona J. Ruiz; Aishwarya Sundaresan; Jin Zhang et al. (2021). Genomic characterization and therapeutic targeting of HPV undetected cervical carcinomas. (external link)
• Hege Fredriksen Berg; Zhenlin Ju; Madeleine Myrvold et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (external link)
• Alice W. Lee; Jonathan P Tyrer; Jennifer A Doherty et al. (2015). Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study. (external link)
• Mac Versluis; Annechien Plat; Marco de Bruyn et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (external link)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (external link)
• Erlend Hodneland; Sathiesh Kumar Kaliyugarasan; Kari Strøno Wagner-Larsen et al. (2022). Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer. (external link)
• Hege Fredriksen Berg; Hilde Renate Engerud; Madeleine Myrvold et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (external link)
• Stig E. Bojesen; Karen A Pooley; Sharon E Johnatty et al. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. (external link)
• Kanthida Kusonmano; Mari Kyllesø Halle; Elisabeth Wik et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (external link)
• Kate Lawrenson; Edwin S. Iversen; Jonathan Tyrer et al. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (external link)
• William J. Gibson; Erling Andre Høivik; Mari Kyllesø Halle et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (external link)
• Henrica Maria Johanna Werner; Anna Berg; Elisabeth Wik et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (external link)
• Reidun Kristin Kopperud; Cecilie Brekke Rygh; Tine Veronica Karlsen et al. (2017). Increased microvascular permeability in mice lacking Epac1 (Rapgef3). (external link)
• Lars Herfindal; Gyrid Nygaard; Reidun Kristin Kopperud et al. (2013). Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets. (external link)
• Even Birkeland; Elisabeth Wik; Siv Mjøs et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (external link)
• Willem Jan van Weelden; Casper Reijnen; Heidi V.N. Küsters-Vandevelde et al. (2021). The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study. (external link)
• Frederik Holst; Henrica Maria Johanna Werner; Siv Mjøs et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (external link)
• Tina Fonnes; Elin Strand; Kristine Eldevik Fasmer et al. (2020). Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models. (external link)
• David Erik Forsse; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (external link)
• Ingvild Løberg Tangen; Therese Bredholt Onyango; Reidun Kristin Kopperud et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (external link)
• Casper Reijnen; Evangelia Gogou; Nicole C.M. Visser et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (external link)
• Tina Fonnes; Ingrid Ovidia Moe Telle; David Erik Forsse et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (external link)
• Kari Strøno Wagner-Larsen; Njål Gjærde Lura; Øyvind Salvesen et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (external link)
• Erling Andre Høivik; Kanthida Kusonmano; Mari Kyllesø Halle et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (external link)
• Casper Reijnen; Willem Jan van Weelden; Martijn S.J.P. Arts et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (external link)
• Sigmund Ytre-Hauge; Øyvind Salvesen; Camilla Krakstad et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (external link)
• Gro Gausdal; Bjørn Tore Gjertsen; Emmet Martin McCormack et al. (2008). Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death. (external link)
• Marta Espevold Hjelmeland; Hilde Eide Lien; Hege Fredriksen Berg et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (external link)
• Henrica Maria Johanna Werner; Jone Trovik; Mari Kyllesø Halle et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (external link)
• Njål Gjærde Lura; Kari Strøno Wagner-Larsen; David Erik Forsse et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (external link)
• Hui Shen; BL Fridley; HL Song et al. (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. (external link)
• Ingfrid S. Haldorsen; Mihaela Lucia Popa; Tina Fonnes et al. (2015). Multimodal imaging of orthotopic mouse model of endometrial carcinoma. (external link)
• Erlend Hodneland; Erling Andersen; Kari Strøno Wagner-Larsen et al. (2024). Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers. (external link)
• David Erik Forsse; Mark Lewis B Barbero Barbero; Henrica Maria Johanna Werner et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (external link)
• Willem Jan van Weelden; Roy I Lalisang; Johan Bulten et al. (2021). Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer. (external link)
• Ganna Chornokur; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. (external link)
• Fatemeh Mazloumi Gavgani; Thomas Karlsson; Ingvild Løberg Tangen et al. (2021). Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells. (external link)
• Ingvild Løberg Tangen; Henrica Maria Johanna Werner; Anna Berg et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (external link)
• Mari Kyllesø Halle; Ane Cecilie Dæhli Munk; Birgit Øvstebø Engesæter et al. (2021). A gene signature identifying CIN3 regression and cervical cancer survival. (external link)
• Martha Chekenya; Camilla Krakstad; Agnete Svendsen et al. (2008). The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. (external link)
• Cecilie Fredvik Torkildsen; Liv Cecilie Vestrheim Thomsen; Ragnar Sande et al. (2023). Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas. (external link)
• Karen Klepsland Mauland; Zhenlin Ju; Ingvild Løberg Tangen et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (external link)
• Heidi Espedal; Hege Fredriksen Berg; Tina Fonnes et al. (2021). Feasibility and utility of MRI and dynamic 18F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer. (external link)
• Thomas Karlsson; Camilla Krakstad; Ingvild Løberg Tangen et al. (2017). Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation. (external link)
• Karen Klepsland Mauland; Elisabeth Wik; Erling Andre Høivik et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (external link)
• KM Cornel; Camilla Krakstad; B Delvoux et al. (2016). High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer. (external link)
• Anna Berg; Erling Andre Høivik; Siv Mjøs et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (external link)
• Linda E. Kelemen; Madalene Earp; Brooke L. Fridley et al. (2018). rs495139 in the TYMS-ENOSF1 region and risk of ovarian carcinoma of mucinous histology. (external link)
• Vikram Rao Bollineni; Sigmund Ytre-Hauge; Ankush Gulati et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (external link)
• Siddhartha P. Kar; Jonathan P. Tyrer; Qiyuan Li et al. (2015). Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. (external link)
• Mari Kyllesø Halle; Marte Sødal; David Erik Forsse et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (external link)
• Gonda F.J. Konings; Karlijn M.C. Cornel; Sofia Xanthoulea et al. (2018). Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach. (external link)
• Heidi Espedal; Jenny Margrethe Lyngstad; Hege Fredriksen Berg et al. (2025). Evaluation of early chemotherapy response by combining static- and dynamic [¹⁸F]FDG-PET with diffusion-weighted MRI in subcutaneous patient-derived endometrial cancer mouse models. (external link)
• Eric Mörth; Kari Strøno Wagner-Larsen; Erlend Hodneland et al. (2020). RadEx: Integrated visual exploration of multiparametric studies for radiomic tumor profiling. (external link)
• Camilla Krakstad; Ingvild Løberg Tangen; Erling Andre Høivik et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (external link)
• Marike S. Lombaers; Karlijn M. C. Cornel; Nicole C. M. Visser et al. (2023). Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer. (external link)
• David Erik Forsse; Hege Fredriksen Berg; Olivera Bozickovic et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (external link)
• Mari Kyllesø Halle; Camilla Krakstad; Hilde Renate Haugen Engerud et al. (2014). Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervix. (external link)
• Julie Andrea Dybvik; Kristine Eldevik Fasmer; Sigmund Ytre-Hauge et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (external link)
• Ingvild Løberg Tangen; Kristine Eldevik Fasmer; Gonda F Konings et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (external link)
• Maartje M. W. Luijten; Willem Jan van Weelden; Roy I. Lalisang et al. (2024). Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma. (external link)
• Mari Kyllesø Halle; Ingvild Løberg Tangen; Hege Fredriksen Berg et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (external link)
• Tina Fonnes; Hege Fredriksen Berg; Therese Bredholt Onyango et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (external link)
• Shannon N. Westin; Zhenlin Ju; Russell R. Broaddus et al. (2015). PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. (external link)
• Akinyemi Ojesina; Lee Lichtenstein; Samuel S. Freeman et al. (2014). Landscape of genomic alterations in cervical carcinomas. (external link)
• Karl Johan Tronstad; Bjørn Tore Gjertsen; Camilla Krakstad et al. (2003). Mitochondrial-targeted fatty acid analog induces apoptosis with selective loss of mitochondrial glutathione in promyelocytic leukemia cells. (external link)
• Nuria Eritja; Mariona Jove; Kristine Eldevik Fasmer et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (external link)
• Erling Andre Høivik; Erlend Hodneland; Julie Andrea Dybvik et al. (2021). A radiogenomics application for prognostic profiling of endometrial cancer. (external link)
• Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (external link)
• Nicole C.M. Visser; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (external link)
• Mari Kyllesø Halle; Olivera Bozickovic; David Erik Forsse et al. (2024). Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. (external link)
• Madeleine Charlotte van der Berg; Hege Fredriksen Berg; Tomasz Stokowy et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (external link)
• Per-Henrik D. Edqvist; Jutta Huvila; Björn Forsström et al. (2015). Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma. (external link)
• Even Birkeland; G Nygaard; Eystein Oveland et al. (2009). Epac-induced Alterations in the Proteome of Human SH-SY5Y Neuroblastoma Cells. (external link)
• Jennifer Permuth-Wey; K Lawrenson; HC Shen et al. (2013). Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. (external link)
• Paul D.P. Pharoah; Mari Kyllesø Halle; Camilla Krakstad et al. (2013). GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. (external link)
• Kristine Eldevik Fasmer; Erlend Hodneland; Julie Andrea Dybvik et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (external link)
• Stefania Bellone; Kyungjo Jeong; Mari Kyllesø Halle et al. (2024). Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. (external link)
• Lorena Alonso-Alconada; Laura Muinelo-Romay; Kadri Madissoo et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (external link)
• Elisabeth Wik; Even Birkeland; Jone Trovik et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (external link)
• Elisabeth Wik; Maria B Ræder; Camilla Krakstad et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (external link)
• Camilla Krakstad; Lars Herfindal; Bjørn Tore Gjertsen et al. (2006). CaM-kinasell-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. (external link)
• Elin Strand; Ingvild Løberg Tangen; Kristine Eldevik Fasmer et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (external link)
• Kate Lawrenson; Qiyuan Li; Siddhartha Kar et al. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. (external link)
• Jone Trovik; Elisabeth Wik; Henrica Maria Johanna Werner et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (external link)
• Sjur Huseby; Gro Gausdal; Thomas Jeffrey Keen et al. (2011). Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. (external link)
• Lars Herfindal; Camilla Krakstad; Lene Elisabeth Myhren et al. (2014). Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3. (external link)
• S.W. Vrede; Willem Jan van Weelden; Nicole C.M. Visser et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (external link)
• Linda E. Kelemen; Kathryn L. Terry; Marc T. Goodman et al. (2014). Consortium analysis of diet-gene interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.. (external link)
• Maria B Ræder; Even Birkeland; Jone Trovik et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (external link)
• Lars Herfindal; Lene Elisabeth Myhren; Rune Kleppe et al. (2011). Nostocyclopeptide-M1: A potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and 1B1. (external link)
• Ingvild Løberg Tangen; Reidun Kristin Kopperud; Nicole C.M. Visser et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (external link)
• Irene Tveiterås Øvestad; Birgit Øvstebø Engesæter; Mari Kyllesø Halle et al. (2021). High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. (external link)
• Kristina Yvonne Kathe Lindemann; Franziska Siegenthaler; Karin Teien Johannesen et al. (2025). Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study. (external link)
• Alice W Lee; Claire Templeman; Douglas A Stram et al. (2016). Evidence of a genetic link between endometriosis and ovarian cancer. (external link)
• Kari Strøno Wagner-Larsen; Erlend Hodneland; Kristine Eldevik Fasmer et al. (2023). MRI-based radiomic signatures for pretreatment prognostication in cervical cancer. (external link)
• Ernest K. Amankwah; Hui-Yi Lin; Jonathan P. Tyrer et al. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. (external link)
• Jodie N. Painter; Tracy A. O'Mara; Andrew P. Morris et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (external link)
• Erlend Hodneland; Julie Andrea Dybvik; Kari Strøno Wagner-Larsen et al. (2021). Automated segmentation of endometrial cancer on MR images using deep learning. (external link)
• Kristine Eldevik Fasmer; Atle Bjørnerud; Sigmund Ytre-Hauge et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (external link)
• Njål Lura; Kari Strøno Wagner-Larsen; Stian Torkildson Ryste et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (external link)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (external link)
• Sigmund Ytre-Hauge; Morteza Esmaeili; Torill Eidhammer Sjøbakk et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (external link)
• Nicole C.M. Visser; Louis J.M. van der Putten; Alex van Egerschot et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (external link)
• Ingvild Løberg Tangen; Jennifer Taylor Venereis; Mari Kyllesø Halle et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (external link)
• Karen Klepsland Mauland; Øyvin Andre Solberg Eng; Sigmund Ytre-Hauge et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (external link)
• Hilde Renate Engerud; Kirsten Øvergaard Hope; Hege Fredriksen Berg et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (external link)
• Tracy A. O'Mara; Dylan M. Glubb; Frédéric Amant et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (external link)
• Heidi Espedal; Kristine Eldevik Fasmer; Hege Fredriksen Berg et al. (2024). MRI radiomics captures early treatment response in patient-derived organoid endometrial cancer mouse models. (external link)
• Hanna Kosberg Bredin; Camilla Krakstad; Erling André Høivik (2023). PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. (external link)
• Lorena Alonso-Alconada; Maria Santacana; Pablo Garcia-Sanz et al. (2015). Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. (external link)
• Kari Strøno Wagner-Larsen; Njål Lura; Ankush Gulati et al. (2025). MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer. (external link)
• Reidun Kopperud; Camilla Krakstad; Frode Selheim et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signaling system. (external link)
• Agnes Jørgensen Eide; Mari Kyllesø Halle; Njål Lura et al. (2023). Visceral fat percentage for prediction of outcome in uterine cervical cancer. (external link)
• Havjin Jacob; Julie Andrea Dybvik; Sigmund Ytre-Hauge et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (external link)
• Kristine Eldevik Fasmer; Ankush Gulati; Julie Andrea Dybvik et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (external link)
• Gro Vatne Røsland; Sissel Elisabeth Dyrstad; Deusdedit Tusubira et al. (2019). Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC.. (external link)
• Bridget Charbonneau; MS Block; WR Bamlet et al. (2014). Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10. (external link)
• Elisabeth Wik; Jone Trovik; Kanthida Kusonmano et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (external link)
• Kari Espolin Fladmark; Odd Terje Brustugun; Gunnar Mellgren et al. (2002). Ca2+/calmodulin dependent protein kinase II is required for microcystin-induced apoptosis. (external link)
• Siv Mjøs; Henrica Maria Johanna Werner; Even Birkeland et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (external link)
• Nigar Sofiyeva; Camilla Krakstad; Mari Kyllesø Halle et al. (2022). APOBEC3A/B deletion polymorphism and endometrial cancer risk. (external link)
• Ankur Chakravarthy; Ian Reddin; Stephen Henderson et al. (2022). Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. (external link)
• Willem Jan van Weelden; Kristine Eldevik Fasmer; Ingvild Løberg Tangen et al. (2019). Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: A retrospective study. (external link)
• Karoline B. Kuchenbäcker; Susan J. Ramus; Jonathan Tyrer et al. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. (external link)
• Hege Fredriksen Berg; Jone Trovik; Marta Espevold Hjelmeland et al. (2025). Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. (external link)
• Hilde Renate Haugen Engerud; Ingvild Løberg Tangen; Ansgar Berg et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (external link)
• Tina Fonnes; Jone Trovik; Per-Henrik D. Edqvist et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (external link)
• Ingvild Løberg Tangen; Camilla Krakstad; Mari Kyllesø Halle et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (external link)
• Frederic Amant; W. Glenn Mccluggage; Henrica Maria Johanna Werner et al. (2021). Incorporating molecular profiling into endometrial cancer management requires prospective studies. (external link)
• Mari Kyllesø Halle; Aishwarya Sundaresan; Jianqing Zhang et al. (2021). Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.. (external link)
• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (external link)
• Camilla Krakstad; Hege Fredriksen Berg; Kristina Yvonne Kathe Lindemann et al. (2024). Frequency of ERBB2-Low Expression in Endometrial Cancer. (external link)
• Anna Berg; Kristine Eldevik Fasmer; Karen Klepsland Mauland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (external link)
• Jirong Long; Wei Zheng; Yong-Bing Xiang et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (external link)
• Hilde Eide Lien; Marta Espevold Hjelmeland; Hege Fredriksen Berg et al. (2025). Multiplex single-cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer. (external link)
• Puk Meijs-Hermanns; Henrica Maria Johanna Werner; Loes Kooreman et al. (2025). Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma. (external link)
• Ryan J. Delahanty; Yong-Bing Xiang; Amanda Spurdle et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (external link)
• Sigmund Ytre-Hauge; Julie Andrea Dybvik; Arvid Lundervold et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (external link)

Letter to the editor

• Stephanie W Vrede; Vit Weinberger; Eva Colas et al. (2025). It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer. (external link)
• Mari Kyllesø Halle; Henrica Maria Johanna Werner; Camilla Krakstad et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (external link)

Journal corrigendum

• Hege Fredriksen Berg; Marta Espevold Hjelmeland; Hilde Eide Lien et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (external link)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (external link)

Doctoral thesis (PhD)

• Tina Fonnes; Camilla Krakstad (2018). Preclinical models and molecular biomarkers. Tools to improve treatment in endometrial carcinoma. (external link)
• Mari Kyllesø Halle; Helga Salvesen; Camilla Krakstad (2017). Molecular alterations suggesting new treatment strategies in uterine carcinomas. (external link)
• Camilla Krakstad (2005). The role of CaMKII and cA-PK in control of cell survival and death. (external link)
• Ingvild Løberg Tangen; Helga Salvesen; Camilla Krakstad (2016). Hormone signaling related factors as biomarkers in endometrial cancer. (external link)

Conference lecture

• Stein Ove Døskeland; Kari Espolin Fladmark; Camilla Krakstad et al. (1998). Distinct apoptotic death forms. Distinct pathways and functions?. (external link)
• Camilla Krakstad; Stein Ove Døskeland (2001). Cell death in HeLa cells. (external link)
• Reidun Kopperud; Camilla Krakstad; Frode Selheim et al. (2003). cAMP effector mechanisms. Novel twists for an "old" signalling system. (external link)
• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2004). cAMP protects neutrophils against TNFa-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)
• Camilla Krakstad (2004). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)
• Camilla Krakstad (2004). Apoptotic phenotypes induced by natural toxins - Okadaic Acid acts by short-circuiting an ancient irradiation induced death pathway. (external link)
• Camilla Krakstad; Anne Elisabeth Christensen; Stein Ove Døskeland (2002). cAMP protects neutrophils against TNF_-induced apoptosis by activation of cAMP-dependent protein kinase (cA-PK), independently of exchange protein directly activated by cAMP (Epac). (external link)

Conference poster

• Lars Herfindal; Frode Selheim; Kjetil Aursland et al. (2002). Effects of a new bioactive substance from a marine microalga on mammalian cells. (external link)
• Lars Herfindal; Camilla Krakstad; Frode Selheim et al. (2001). TWO NOVEL APOPTOSIS-MODULATION SUBSTANCES ISOLATED FROM MARINE MICRO-ALGAE. (external link)
• Lars Herfindal; Lene Elisabeth Myhren; Rune Kleppe et al. (2010). Liver specific transporters of microcystins as a tool to find novel inhibitors of OATP1B1 and OATP1B3. (external link)
• Tone Sandal; Camilla Krakstad; Nina Ånensen et al. (2003). Myeloid leukemia cell differentiation by bcl-2 and camp involves induction of ccaat/enhancer binding protein ? (c/ebp?), nuclear accumulation of c/ebp?, and direct interaction between bcl-2 and c/ebp?. (external link)

Academic literature review

• Eva Baxter; Donal J. Brennan; Jessica N. McAlpine et al. (2020). Improving response to progestin treatment of low-grade endometrial cancer. (external link)
• Cristian P. Moiola; Carlos Lopez-Gil; Silvia Cabrera et al. (2018). Patient-derived xenograft models for endometrial cancer research. (external link)
• Camilla Krakstad; Martha Chekenya (2010). Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. (external link)
• Jenneke C. Kasius; Johanna M. A. Pijnenborg; Kristina Lindemann et al. (2021). Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. (external link)
• Antoinette Hollestelle; Frederieke H Van Der Baan; Andrew Berchuck et al. (2016). No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (external link)
• Andreas Obermair; Eva Baxter; Donal J. Brennan et al. (2020). Fertility-sparing treatment in early endometrial cancer: Current state and future strategies. (external link)
• Rune Kleppe; Camilla Krakstad; Frode Selheim et al. (2011). The cAMP-dependent protein kinase pathway as therapeutic target - possibilities and pitfalls. (external link)
• Heidi Espedal; Tina Fonnes; Kristine Eldevik Fasmer et al. (2019). Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. (external link)
• Fatemeh Mazloumi Gavgani; Victoria Smith Arnesen; Rhian Gaenor Jacobsen et al. (2018). Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer. (external link)

Master’s thesis

• Frode Selheim; Camilla Krakstad; Even Birkeland (2008). Quantitative proteomics of Epac signaling in differentiating human SH-SY5Y neuroblastoma cells. (external link)
• Lise Fismen; Kari Espolin Fladmark; Camilla Krakstad (2005). Role of Cu/Zn superoxide dismutase (SOD1) in phosphatase inhibitor-induced apoptosis. (external link)
• Marie Louise Ljones; Camilla Krakstad; Frode Selheim (2008). Epac-induced neuronal differentiation of Human SH-SY5Y neuroblastoma cells. (external link)

Academic book chapter

• Gro Gausdal; Camilla Krakstad; Lars Herfindal et al. (2007). Serine/Threonine Protein Phosphatases in Apoptosis. (external link)
• Helga Birgitte Salvesen; Henrica Maria Johanna Werner; Camilla Krakstad (2013). PI3K Pathway in Gynecologic Malignancies. (external link)

Conference abstract

• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (external link)
• Ingvild Løberg Tangen; Camilla Krakstad; Henrica Maria Johanna Werner et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (external link)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (external link)

See a complete overview of publications in NVA.